drugset / Trial / NCT01316133

A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

NCT01316133 ↗

Phase 4 Terminated 37 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate efficacy and safety of tacrolimus with steroid by observing remission rate at 24 weeks in lupus nephritis patients who are non-responders to steroid monotherapy.

Timeline

Start
2011-04-19
Primary completion
2016-04-08
Completion
2016-04-08

Outcome

Outcome not reported

Stopped (Enrollment): “Study terminated due to poor patient recruitment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Oral

Indications